Form 8-K - Current report:
SEC Accession No. 0000939767-25-000049
Filing Date
2025-03-31
Accepted
2025-03-31 16:05:30
Documents
14
Period of Report
2025-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K exel-20250331.htm   iXBRL 8-K 24623
3 GRAPHIC exel-20250331_g1.jpg GRAPHIC 55431
  Complete submission text file 0000939767-25-000049.txt   283263

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20250331.xsd EX-101.SCH 1798
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20250331_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20250331_pre.xml EX-101.PRE 12522
17 EXTRACTED XBRL INSTANCE DOCUMENT exel-20250331_htm.xml XML 2806
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0103
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 25793126
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)